Contact

Our portfolio

SigmaScreening

SigmaScreening has developed a mammography device that reduces pain and improves diagnostic accuracy. Founded by Amsterdam UMC professors, the company aims to enhance breast cancer detection with their patented technology. SigmaScreening has licensed their technology to Teledyne, who continue development of the device.

  • Institute: Amsterdam UMC
Industry: Imaging, Medical Technology, Oncology
  • Founding year: 2010

Want to get in contact about SigmaScreening?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

SolarFoil
Enhancing plant growth with solar-powered nanotechnology.
Primagen
Investing in and developing molecular diagnostics for biotech innovation.
InSteps
Digitizing stroke treatment development and planning with an in-silico stroke simulation platform.
CRCbioscreen
Developing stool-based colorectal cancer screening for early detection.
SolarFoil
Enhancing plant growth with solar-powered nanotechnology.
Primagen
Investing in and developing molecular diagnostics for biotech innovation.
InSteps
Digitizing stroke treatment development and planning with an in-silico stroke simulation platform.
CRCbioscreen
Developing stool-based colorectal cancer screening for early detection.
Explore full AAV portfolio
Contact